Structure of Yin Yang 1 oligomers that cooperate with RuvBL1-RuvBL2 ATPases by López-Perrote, Andrés et al.
Structure of Yin Yang 1 Oligomers That Cooperate with
RuvBL1-RuvBL2 ATPases*
Received for publication,March 19, 2014, and in revised form, May 22, 2014 Published, JBC Papers in Press, July 2, 2014, DOI 10.1074/jbc.M114.567040
Andrés López-Perrote‡, Hanan E. Alatwi§, Eva Torreira‡, Amani Ismail§, Silvia Ayora¶, Jessica A. Downs§1,
and Oscar Llorca‡2
From the ‡Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro deMaetzu 9, 28040
Madrid, Spain, §GenomeDamage and Stability Centre, University of Sussex, Science Park Road, Falmer, Brighton BN1 9RQ, United
Kingdom, and ¶Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Darwin 3, 28049 Madrid, Spain
Background:Oligomerization of transcription factor YY1 is not well understood.
Results: YY1 assembles homo-oligomers that bind DNAs without the consensus sequence, whose structure is studied by
electron microscopy.
Conclusion: RuvBL1-RuvBL2 enhances YY1 binding to DNAs without the consensus sequence for the transcription factor.
Significance: YY1-RuvBL1-RuvBL2 complexes could contribute to functions beyond transcription, and we find this occurs
during homologous recombination.
Yin Yang 1 (YY1) is a transcription factor regulating prolifer-
ation and differentiation and is involved in cancer development.
Oligomers of recombinant YY1 have been observed before, but
their structure and DNA binding properties are not well under-
stood. Here we find that YY1 assembles several homo-oligo-
meric species built from the association of a bell-shaped dimer,
a process we characterized by electron microscopy. Moreover,
we find that YY1 self-association also occurs in vivo using bimo-
lecular fluorescence complementation. Unexpectedly, these
oligomers recognize several DNA substrates without the con-
sensus sequence for YY1 in vitro, and DNA binding is enhanced
in the presence of RuvBL1-RuvBL2, two essential AAA
ATPases. YY1 oligomers bind RuvBL1-RuvBL2 hetero-oligo-
meric complexes, but YY1 interacts preferentially with RuvBL1.
Collectively, these findings suggest that YY1-RuvBL1-RuvBL2
complexes could contribute to functions beyond transcription,
and we show that YY1 and the ATPase activity of RuvBL2
are required for RAD51 foci formation during homologous
recombination.
Yin Yang 1 (YY1)3 is a polycomb group transcription factor
that regulates important cellular events through activation or
repression of transcription. YY1 is ubiquitously expressed in
many tissues and participates in replication, differentiation,
proliferation, embryogenesis, and development (1–4). YY1
overexpression in some tumors correlateswith recurrences and
bad prognosis, and YY1 has been proposed as a marker for
cancer progression (5). Interestingly, recent reports have
broadened the spectrum of processes regulated by YY1 such as
silencing of retro-elements in embryonic cells (6), regulation of
long noncoding RNAs (7), inactivation of the X chromosome in
the females of mammals (4), and a direct role in V(D)J recom-
bination during early B-cell development (8).
Human YY1 is a 414-amino acid protein with a predicted
molecular mass of 44 kDa and highly conserved in eukaryotes
(sequence identity between human and mouse98%) (1) (Fig.
1A). Putative structural and functional homologs in Schizosac-
charomyces pombe (Iec1) (9) and Drosophila melanogaster
(PHO (pleiohomeotic) and PHOL (pleiohomeotic-like)) (10)
have been studied. YY1 hallmark is four C2H2-type zinc finger
motifs located at its C terminus (residues 298–397), responsi-
ble for the sequence-specific recognition of a consensus DNA
sequence (5-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3, where
the uppercase letters indicate the preferred base for each posi-
tion) being themost frequent ACAT and CCAT. This C-termi-
nal region harbors part of the transcriptional repression activity
of YY1. The co-crystal structure of residues 293–414 bound to
the adeno-associated virus P5 promoter showed the four zinc
fingers interacting with the DNA major groove. The structure
revealed that the interaction with the consensus sequence is
defined by specific contacts between YY1 side chains and bases
of the DNA (11). Less is known about other segments of the
protein. The N terminus has been implicated in transcriptional
activation, whereas residues 170–201 participate in transcrip-
tional repression (12, 13). Residues 201–226 form the REPO
(recruitment of polycomb) domain, involved in polycomb
group repression (14).
There is evidence that YY1 is important for maintaining
genome stability (15), but this could in part work through its
role as a transcriptional regulator of genes involved in DNA
damage responses (16, 17). Yet YY1 could also have a direct role
in DNA damage responses as it has been shown that YY1-
INO80 complexes may function in DNA repair by homologous
recombination (HR) (15). INO80 is a multisubunit chromatin-
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remodeling complex that includes, in addition to YY1 and the
Ino80 catalytic subunit, RuvBL1 and RuvBL2 (18, 19), two
closely related (65% sequence similarity) AAA (ATPases
associated with diverse cellular activities) proteins (20, 21).
They share homology with RuvB, the prokaryotic helicase
involved in Holliday junction (HJ) resolution during HR. RuvB
assembles as hexameric rings, and its DNA-dependent ATPase
activity provides the energy for branch migration (22). RuvBL1
and RuvBL2 are essential in multiple processes including tran-
scription, DNA repair, and nonsense-mediated mRNA decay,
and their overexpression is associated with tumorigenesis
(20, 21).
X-ray crystallography (23–25) and electron microscopy
(EM) (26–28) revealed that RuvBL1 and RuvBL2 are organized
in three domains. Domain I (DI) and III (DIII) comprise the
catalytic ATPase core, responsible for the oligomerization in
homo-hexameric rings with a central channel. RuvBL1 and
RuvBL2 also assemble hetero-oligomers with alternating
RuvBL1 andRuvBL2 subunits (23–25). DII is a unique insertion
connected to the ATPase core, resembling an OB-fold, and
recombinant DII domains of RuvBL1 interact with ssDNA,
dsDNA, and ssRNA in vitro (23–25). Using cryo-EM we
recently solved the structure of human RuvBL1-RuvBL2 com-
plexes assembled as hetero-dodecamers composed of two
hexameric rings interacting back-to-back (27). These do-
decamers co-existed in two different conformations whose
functional significance is still unclear. RuvBL1 and RuvBL2
interact with YY1 in vitro (15), but these complexes have not
been characterized in detail.
Although there is evidence that YY1 can oligomerize in vitro
(15), little is currently known about the structure or DNA bind-
ing activity of these oligomeric complexes. Moreover, it is not
known if YY1 forms oligomers in vivo. Here we have analyzed
the assembly of YY1 using EM, and we determine the low res-
olution architecture of these YY1 oligomers, providing new
structural information on full-length YY1. In addition, we also
provide evidence of YY1 self-association in vivo. Interestingly,
we find that YY1 oligomers bind to several DNA substrates
without the consensus sequence for YY1 as a transcription fac-
tor. These oligomers also bind to RuvBL1-RuvBL2 ATPases in
vitro, andwe find that RuvBL1-RuvBL2 enhances DNAbinding
byYY1.These findings help explain someunconventional func-
tions ascribed to YY1 recently that could hardly be understood
only on the basis of its function as a transcription factor. We
explore one of these, and we show that, consistent with previ-
ous results (15), YY1 and RuvBL1-RuvBL2 cooperate during
DNA repair, but in addition our results indicate these proteins
are required for the correct assembly of RAD51 filaments and
that this function is dependent on RuvBL2 ATPase activity.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant Proteins—His-
YY1 was expressed using Escherichia coli Origami (DE3) cells,
and induction was performed by the addition of 0.5 mM isopro-
pyl 1-thio--D-galactopyranoside (final concentration) at 37 °C
for 3 h. For Strep-II-YY1, BL21 (DE3) cells were used, and
induction was carried out by the addition of 0.1 mM isopropyl
1-thio--D-galactopyranoside (final concentration) at 28 °C for
4 h. In both cases the medium was supplemented with 0.1 mM
ZnCl2 (final concentration) at the time of induction, and cell
lysis was performed by sonication in 100 mM Na2HPO4/
NaH2PO4, 300mMNaCl, 0.1mMZnCl2 containing amixture of
proteases inhibitors (Roche Applied Science). His-YY1 was
purified by affinity chromatography using a HisTrap HP col-
umn (GE Healthcare) equilibrated in 100 mM Na2HPO4/
NaH2PO4, 300 mM NaCl, 50 mM imidazole, 0.1 mM ZnCl2 fol-
lowed by a cationic exchange Mini S PC 3.2/3 (GE Healthcare)
column. Purified His-YY1 was dialyzed against 50 mM Tris-
HCl, pH 7.4, 200 mM NaCl, 10% (v/v) glycerol, 0.1 mM ZnCl2
overnight and stored at 80 °C. Strep-II-YY1 was purified in
one step using a StrepTrap HP column (GE Healthcare) equil-
ibrated in 50 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10% (v/v)
glycerol, 0.1 mM ZnCl2, and eluted using 2.5 mM D-desthiobio-
tin in the same buffer. Purified Strep-II-YY1was dialyzed in the
same buffer as His-YY1 and stored at 80 °C. In all cases, size
exclusion chromatography (SEC) was used as a final step of
purification using a BioSep-SEC-S4000 (Phenomenex) or a
Superdex 200 PC 3.2/30 column (GE Healthcare) equilibrated
in 50mMTris-HCl, pH7.4, 200mMNaCl, 10% (v/v) glycerol, 0.1
mM ZnCl2.
His-RuvBL1 and His-RuvBL2 were expressed in BL21 (DE3)
cells by induction with 0.1 mM isopropyl 1-thio--D-galactopy-
ranoside (final concentration) at 28 °C for 4 h. They were puri-
fied by affinity chromatography using a HisTrap HP column
(GE Healthcare) equilibrated in 50 mM Tris-HCl, pH 7.4, 300
mMNaCl, 10% (v/v) glycerol, 20mM imidazole and eluted using
a gradient of 20–500 mM imidazole. Fractions containing the
proteins were pooled and dialyzed overnight at 4 °C in 25 mM
Tris-HCl, pH 7.4, 250mMNaCl. In the indicated cases, SECwas
performed using a Superdex 200 PC 3.2/30 (GE Healthcare) or
Superdex 200 10/300 GL (GE Healthcare) column equilibrated
in 50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 10% (v/v) glycerol.
His-RuvBL1-RuvBL2 and RuvBL1-RuvBL2 were produced as
described (27).
Affinity Purification of YY1-RuvBL1-RuvBL2 Complexes—
Recombinant Strep-II-YY1 was used to test interactions with
His-RuvBL1, His-RuvBL2, His-RuvBL1-RuvBL2, and RuvBL1-
RuvBL2 proteins in vitro. Pulldown assays were performed by
incubation of purified Strep-II-YY1 with a 2-fold molar excess
of the purified partner (His-RuvBL1, His-RuvBL2, His-
RuvBL1-RuvBL2, or RuvBL1-RuvBL2) in 50 mM Tris-HCl, pH
7.4, 500 mM NaCl, 10% (v/v) glycerol, 0.1 mM ZnCl2 for 20 min
on ice followed by the addition of StrepTactin High Perform-
ance Resin (GE Healthcare) and further incubation for 30 min
at 4 °C with agitation. After 3 washes with the reaction buffer,
proteins retained in the resin were elutedwith 50mMTris-HCl,
pH 7.4, 500mMNaCl, 10% (v/v) glycerol, 0.1 mMZnCl2, 2.5 mM
D-desthiobiotin. All purification steps were monitored by SDS-
PAGE, and protein detection was carried out using Oriole
Fluorescent Gel Stain (Bio-Rad) or silver staining.
Glutaraldehyde Cross-linking—Purified His-YY1 (0.1 g/l)
was dialyzed in 100mMNa2HPO4/NaH2PO4, 300mMNaCl, 0.1
mM ZnCl2 for 3 h, and 13.5 l of the protein were cross-linked
in 15-l reactions on ice using glutaraldehyde 0.005% (v/v)
(final concentration) for 30 min. The reactions were stopped
using 192 mM Tris-glycine (final concentration). Samples were
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analyzed by SDS-PAGE and Western blotting using the anti-
YY1 antibody.
GraFix—Affinity-purified Strep-II-YY1 (10 M) was stabi-
lized in a discontinuous glycerol/glutaraldehyde gradient by the
GraFix method (29). 100 l of the sample were applied on the
top of the tube. As a control, sample was also applied into a
similar glycerol gradient without the cross-linking agent. Sam-
ples were centrifuged at 30,000 rpm, 4 °C for 18 h (rotor SW 55
Ti). After centrifugation, fractions were collected, and reac-
tions stopped by the addition of 192 mM Tris-Glycine (final
concentration).
Electron Microscopy and Image Processing—A few microli-
ters of each of the samples analyzed were deposited on carbon-
coated grids immediately after elution from the SEC column
and stained using 2% (w/v) uranyl acetate. All observations
were performed in a JEOL 1230 transmission electron micro-
scope operated at 100 kV. Images were collected using a low-
dose protocol and a 4k x 4k TVIPS CMOS detector under con-
trol of the EM-TOOLS software (TVIPS). Final magnification
of the CMOS micrographs was 68222.5. Contrast transfer
function for each micrograph was estimated using CTFFIND3
(30) and corrected using BSOFT (31) before selecting particles.
Particles were boxed and extracted from themicrographs using
e2boxer in EMAN2 (32). 16362 particles for complex A and
52713 particles for complex B were boxed and classified using
reference-free methods in EMAN (33), EMAN2 (32), and
XMIPP (34). Particles were binned at 4.56 Å/pixel before fur-
ther processing. Ab initio structures for each experiment were
obtained by the random conical tilt (RCT) method (35) using
XMIPP (34). RCT was applied on those molecule images clas-
sified as belonging to the same view of the oligomer and using
the images of these same molecules after tilting the specimen
holder by 45°. The resulting volumes were then used as tem-
plates for angular refinement using EMAN (33). The rotational
symmetry of the YY1 complexes was determined by calculating
the power rotational spectra of sections of the RCT structures
generated using SPIDER (36) along the longitudinal axis of the
complex, as implemented in XMIPP (34), as well as for the
reference-free two-dimensional averages. Refinement was per-
formedwithout assuming any symmetry, but after some rounds
of refinement 2-fold rotational symmetry was imposed and
refined further until convergence. The hand selected was that
provided by the RCT structure. The resolution of the structure
(20 Å) was estimated using Fourier shell correlation (FSC) and
a 0.5 correlation coefficient. We verified that the bias of the
template used for angular refinement did not affect conver-
gence significantly. For this, we refined the same dataset from
four independent templates and imposing 2-fold symmetry.
Images were refined from: (i) a RCT structure; (ii) a structure
obtained using the common lines method as implemented in
the startAny command from EMAN (33); (iii) a model gener-
ated using the startcsym program from EMAN (33), searching
for particleswith the best 2-fold rotational symmetry, which are
the defined as top views, and for particles with the best mirror
symmetry and poor 2-fold symmetry, defined as sided views;
class averages from each group and the 2-fold symmetry were
used to generate a three-dimensional model; (iv) a model was
generated using e2initialmodel.py in EMAN2 (32), where a ran-
dom featureless blob model is used to seed a refinement using
reference-free class averages. All structures were filtered
according to the estimated resolution and rendered using
UCSF Chimera (37).
DNA Substrates—DNAs were made by annealing combina-
tions of oligonucleotides (Table 1). In each case one of the oli-
gonucleotides was labeled at the 5-end by polynucleotide
kinase with [-32P]ATP before annealing. Holliday junction J3,
which has 40-bp arms, was made from oligonucleotides J3-1 to
J3-4, the duplex dsDNA_no_sp_1 (not containing the consen-
sus sequence) from J3-2 and J3-5, and dsDNA_sp_1 (containing
the consensus sequence) from 43-1 and 43-2. The 80-nt ssDNA
substrate used was labeled J3-2 oligonucleotide. Holliday junc-
tion HJ_25 (with 25-bp arms) was made from oligonucleotides
HJ_1 to HJ_4. Annealing was performed in 100 mM phosphate
buffer, pH 7.5, with the appropriate combinations of oligonu-
cleotides, mixing one radiolabeled oligonucleotide with cold
complementary oligonucleotides in a 1:2 ratio. The annealed
products were resolved on an 8% non-denaturing polyacryl-
amide gel. The bands containing the annealed substrates were
purified as described in Zecchi et al. (38). DNA concentration
was calculated by scintillation counting. DNA substrates
labeled with Cy5 (Sigma) at the 5-end were annealed as
described for the -32P-labeled substrates. Holliday junction
HJ_25_sp was made from oligonucleotides HJ_12 and HJ_34_1
andHJ_25_no_sp fromHJ_12 andHJ_34_2. dsDNA containing
(dsDNA_sp_2) or not (dsDNA_no_sp_2) the consensus
sequence for YY1 were made from oligonucleotides DS_1 and
DS_2, and DS_3 and DS_4, respectively.
Electrophoretic Mobility Shift Assays (EMSA)—Binding of
YY1 andRuvBL1-RuvBL2 toDNAwas analyzed throughEMSA
using different radiolabeledDNAsubstrates (0.3 nM). Reactions
were performed in 50mMTris-HCl, pH7.5, 0.05mg/mlBSA, 60
mMNaCl, 10% (v/v) glycerol, 1 mMMgCl2, 0.1 mMZnCl2, 1 mM
DTT for 30 min at 37 °C. Complexes were separated by 8 or 6%
native-PAGE in Tris borate-EDTA 0.5 at 4 °C. Gels were run
at 200 V for 3 h and dried before autoradiography and phos-
phorimaging. Apparent binding constants were determined as
the protein concentration resulting in half binding to a DNA
substrate at 0.3 nM by EMSA. The exact value of the half-bind-
ing point was determined from interpolation on a Hill plot.
Binding constants are the average values obtained from at least
three independent experiments (the results given stand within
a 10% standard error).
For the supershift experiments, reactions were carried out in
the same conditions as those for the binding assays, but after
incubation at 37 °C for 30 min, the indicated amounts of anti-
YY1 antibody or PBS 1 as a controlwas added to reactions and
further incubated for 15 min at 37 °C. Samples were separated
under the same conditions as those described before for the
binding assays. Binding of YY1 fractions from the SEC to Cy5-
labeled DNA (10 nM) substrates was also analyzed through
EMSA. Reactionswere carried out on ice for 30min in buffer 50
mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% (v/v) glycerol, 10 mM
MgCl2, 0.1 mM ZnCl2. Complexes were solved on 6% native-
PAGE gels in Tris borate-EDTA 0.5 at 4 °C. Fluorescence of
the DNA was detected with a Fujifilm FLA-3000 equipment.
Native-PAGE gels were transferred to PVDF membranes, and
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protein was detected by Western blot with the anti-YY1
antibody.
Cell Culture and Irradiation—A549 and U2OS cells were
cultured in Eagle’s minimum essential medium (MEM) or
DMEM (Invitrogen), respectively, supplemented with 10%
FCS, L-glutamine, penicillin, and streptomycin (Invitrogen) at
37 °C in a humidified 95% air and 5% CO2 atmosphere. Cells
were irradiated by exposure to a 137Cs source.
Small Interfering RNA (siRNA) Knockdown Conditions and
Antibodies—siRNA-mediated knockdown was achieved using
HiPerFect Transfection Reagent (Qiagen) following the man-
ufacturer’s instructions. siRNA duplexes were transfected into
4  105 of logarithmically growing cells per condition. Cells
were harvested 24 h later, retransfected with siRNA, and then
seeded and grown for 48 h. The primary antibodies used were:
H2AX (Millipore) at 1:800 for IF, replication protein A (RPA;
Millipore) at 1:100 for IF, RAD51 (SantaCruzBiotechnology) at
1:200 for IF, CENPF (Abcam) at 1:1000 for IF, YY1 (H-414,
Santa Cruz Biotechnology) at 1:1000 forWB, RuvBL2 (Abcam)
at 1:5000 for WB, and KAP-1 (Abcam) at 1:1000 for WB. Anti-
YY1 antibody (H-10 X, Santa Cruz Biotechnologies) for super-
shift experiments was used. The secondary antibodies used
were: FITC (Sigma) at 1:100 for IF, Cy3 (Sigma) at 1:200 for IF,
AlexaFluor 488/555/350 (Invitrogen) at 1:400 for IF, goat anti-
rabbit HRP at 1:10,000 for WB, rabbit anti-mouse HRP at
1:2,000 for WB. Anti-His-HRP conjugated antibody (Sigma)
was used at 1:10,000 for WB.
Bimolecular Fluorescence Complementation (BiFC)—1.5 
105 of U2OS cells were co-transfected with 0.25 g of VN173-
and VC155-derived plasmids using a NanoJuice Transfection
Reagent kit (Novagen). 24 h post-transfection cells were fixed
with 3% (w/v) paraformaldehyde, permeabilized with 0.5% Tri-
ton X-100, and mounted with Vectashield containing 4,6-di-
amidino-2-phenylindole (DAPI; Vector Laboratories Ltd).
Slides were analyzed and imaged using an Applied Precision
Delta Vision RT Olympus IX70 deconvolution microscope.
Immunofluorescence—Cells plated on coverslips were fixed
for 10 min with fixative (2% (w/v) paraformaldehyde, 3% (w/v)
sucrose, 1 PBS) and permeabilized for 3minwith 0.2%Triton
X-100 in PBS.When staining for RPA/RAD51 in cells not trans-
fected with plasmid, pre-extraction was performed by treat-
ment with 0.2%Triton X-100 in PBS for 0.5–1min before para-
formaldehyde fixation. Cells were rinsed with PBS and
incubated with primary antibody diluted in PBS  2% (w/v)
BSA for 1 h at room temperature. Cells were washed 3 times,
incubated with secondary antibody (diluted in PBS 2% (w/v)
BSA) for 30 min at room temperature in the dark, incubated
withDAPI for 10min, andwashed 3 timeswith PBS. Slideswere
mounted using Vectashield and visualized/analyzed using a
Nikon-e400 microscope and imaged using an Applied Preci-
sion Delta Vision RT Olympus IX70 deconvolution micro-
scope and softWoRx Suite software. For H2AX, RPA, and
RAD51 foci quantification, a minimum of 30 cells were scored
blindly per experiment, and error bars represent the S.D.
between three experiments.
Plasmids and Constructs for in Vivo Studies—The BiFC plas-
mids pBiFC-VN173 (encoding the N-terminal region of Venus;
Addgene no. 22010) and pBiFC-VC155 (encoding the C-termi-
nal region of Venus; Addgene no. 22011) were obtained from
Chang-Deng Hu (via Addgene (49)). The coding region of YY1
was amplified from the YY1 cDNA (Source BioScience) and
cloned into the BiFC plasmids to create pYY1-VN and pYY1-
VC.TheRuvBL2 complete humanORF cDNA (accession num-
ber NM_006666) was purchased from Origene as GFP-tagged
transfection-ready DNA. To generate siRNA-resistant RuvBL2
expression constructs, the following nucleotides weremutated:
451 G to A, 460 A to T, 466 A to T using QuikChange
site-directed mutagenesis (Stratagene). The GFP-RuvBL2K83A
ATPase mutant construct was generated using QuikChange
site-directed mutagenesis (Stratagene) on the siRNA-resistant
template.
RESULTS
YY1 Assembles Two Distinct Oligomeric Species—Human
full-lengthHis-tagged YY1 (His-YY1)was expressed in bacteria
and purified to homogeneity (Fig. 1B) for structural and bio-
chemical studies. His-YY1migrated with the apparentmobility
of a larger protein (65–68 kDa) due to its amino acid compo-
sition (39). We analyzed the functionality of the recombinant
protein by testing the ability of His-YY1 to bind DNA using
synthetic 4-way DNA substrates (HJ) by EMSA (Fig. 1C). His-
YY1 bound two types of HJ with arms of 40 bp (Fig. 1C, left
panel) and 25 bp (Fig. 1C, right panel). The shifted band was
specifically super-shifted with an anti-YY1 antibody unable to
shift DNA complexes of the RecU resolvase used as a control
(not shown). Therewere severalHis-YY1DNAcomplexes, sug-
gesting the binding of multiple monomers to each DNA mole-
cule and opening the possibility of YY1 oligomerization (15).
Confirming the work by Wu et al. (15), we found that His-
YY1 behaved as an oligomer in a SEC (Fig. 1D), but in addition
we observed that His-YY1 migrated as two distinct species, an
100–150-kDa complex (named as complex A) and a larger
oligomer of about 200–300 kDa (complex B). Complex A could
correspond to a 2- or 3-mer according to the calibration of the
column using molecular weight standards (Fig. 1D), and this
complex appeared as square-shaped molecules compatible
with an oligomer by EM (Fig. 1E). Complex B appeared at the
microscope as an elongated molecule with roughly double
length than complex A (Fig. 1E). Some larger species were also
detected eluting from the column (Fig. 1D), but they appeared
as aggregates in the electron microscope (Fig. 1E, inset). Oligo-
merization was also detected by analyzing the electrophoretic
mobility of His-YY1 after a mild cross-linking using glutaralde-
hyde, which showed the presence of multimers containing sev-
eral subunitsmigrating as dimers and also larger oligomers (Fig.
1F). Several lines of evidence revealed that complex B was
assembled by the oligomerization of complex A, as the ratio
between complex B and A in SEC was dependent on the input
sample concentration. When fractions from the SEC corre-
sponding to complex B were re-injected in the same column, a
peak containing His-YY1 that migrates as complex A and con-
taining square-shaped molecules was detected (Fig. 1G). This
was interpreted as resulting from the disassembling of the
larger species, suggesting an equilibrium between the two
oligomers.
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YY1 FormsMultimers in Vivo—Whether the oligomerization
of YY1 found for the recombinant protein also occurs in vivo is
unknown. Thus we used BiFC to detect YY1 self-association in
vivo. We created two YY1 fusion constructs with complemen-
tary fragments (VN orVC) of the YFP fluorescent reporter pro-
tein Venus (Fig. 2A). Fluorescence occurs when the comple-
mentary fragments of Venus are in close proximity, providing
readout of protein-protein interactions in vivo. We co-trans-
FIGURE 1. Purification and characterization of human YY1. A, scheme of
human YY1 primary sequence. Relevant domains andmotifs are indicated. B,
SimplyBlue (Invitrogen) staining SDS-PAGE of purified His-YY1. C, left panel,
His-YY1 was incubated with a synthetic HJ DNA (described as J3 under
“Experimental Procedures”), and reactions were resolved by 6% non-de-
naturating PAGE. 0.3 nM of HJ (J3) (lane 1) was titrated with increasing
amounts of YY1 (lanes 2–7, 1920, 960, 480, 240, 120, and 60 nM, respec-
tively). Right panel, antibody super shift experiments demonstrated the
specificity of the interaction. Lane 1, HJ probe alone (described as
HJ_25_no_sp under “Experimental Procedures”); lanes 2 and 3, 2 and 1 g
of anti-YY1 antibody (Ab) alone, respectively; lane 4, YY1 protein alone
(100 nM); lanes 5 and 6, incubation of YY1 protein (100 nM) with 2 and 1 g
of anti-YY1 antibody, respectively. Positions of unboundHJ probe, YY1-HJ,
and YY1-HJ-antibody shifted-bands are indicated. D, SEC of purified His-
YY1 in a BioSep-SEC-S4000 (Phenomenex) column. The column was cali-
brated with molecular weight standards (GE Healthcare), and the elution
volume for some of the standards is shown on the top of the chromato-
gram. E, different fractions from the SEC inDwere observed in the electron
microscope, and fields from representative electron micrographs are
shown. Typical molecule images are highlighted within circles. The inset in
the left panel shows a view of aggregates found to elute first from the SEC
column. The scale bar represents 250 Å. F, Western blot with an anti-YY1
antibody of His-YY1 after cross-linking with glutaraldehyde (GA); lane 1,
molecular weight standards (Bio-Rad); lane 2, control without GA; lane 3,
30 min of incubation with GA. His-YY1 monomer migrates as a 70-kDa
protein in SDS-PAGE (labeled as *). Cross-linked bands, with a relative
molecular weight multiples of the YY1 monomer, are labeled with arrows.
G, SEC of His-YY1 was as in D (black line). The peak fraction corresponding
to complex B was re-injected (gray line) in the same column, and the frac-
tions (F1 to F10) of both experiments were analyzed by silver-stained
SDS-PAGE. The top panel corresponds to fractions from the black line and
bottom panel for the gray line chromatography, respectively. Positions of
the YY1 complexes A and B as well as molecular weight standards (GE
Healthcare) used for column calibration are indicated. Total volume of the
column (Vt) is indicated by an asterisk (*).
FIGURE 2. YY1multimerizes in vivo. A, scheme of the expression constructs
used inBiFCexperiments. The coding sequenceof YY1was fused to either the
N-terminal (YY1-VN) or C-terminal (YY1-VC) domain of Venus. B, U2OS cells
transiently co-transfected with plasmids expressing the fusions in A were
analyzed by microscopy. Co-transfection of YY1-VN with VC or YY1-VC with
VN displayed no difference in pan-nuclear fluorescence compared with cells
co-transfected with the empty vectors (VC and VN). Only cells co-transfected
with both YY1 fusion constructs (YY1-VN and YY1-VC) had distinct foci pres-
ent in the nuclei.
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fected cellswith theYY1-VNandYY1-VC fusion constructs. As
controls, cells were transfected with YY1-VN in combination
with the VC empty vector (YY1-VN and VC), YY1-VCwith the
VN empty vector (VN and YY1-VC), or the two empty vectors
(VN and VC). In all of the control cells, we saw pan-nuclear
fluorescence. However, when the YY1 constructs were co-
transfected, we saw distinct foci present in the cells (Fig. 2B),
suggesting that YY1 forms multimers in vivo.
YY1Assembles a Bell-shapedCoreDimer—To further under-
stand the structure of the YY1 multimers, an homogenous
preparation of complex A from the peak fraction of a SEC
experiment was observed by EM, revealing a square-shaped
molecule with approximate dimensions of 60  50 Å, a low
density region at its center (Fig. 3A), and a clear maximum in
4-fold rotational power spectra compatible with the oligomer-
ization of 2 or 4 identical YY1 subunits (Fig. 3B, left panel).
Several low resolution ab initio structures of YY1 complex A
were obtained for homogenous sub-classes using the RCT
method (Fig. 3C, four representative RCT structures are
shown). Sections along the longitudinal axis of these ab initio
structures revealed a square shape (Fig. 3C), with a 4-fold
maximum in the rotational power spectra (Fig. 3B, right
panel). Given that the SEC experiment suggested that YY1
oligomers are either 2- or 3-mers but never 4-mers, the
FIGURE3.Structureof thehumanYY1dimer.A, singlemolecule images and two-dimensional reference-free averages of complexAofHis-YY1 showa typical
square shape. The scale bar represents 5 nm. B, left panel, analysis of the rotational power spectra of a representative reference-free two-dimensional (2D)
average of YY1. Right panel, rotational power spectra of sections along the longitudinal axis of the YY1 RCT structure. One representative section is displayed
that revealed a strong componentwith 4-fold symmetry compatiblewith a dimeric or tetrameric complex. Scale bars represent 5 nm. C, four representative ab
initio low resolution structures of YY1 complex A obtained by the RCT method. Two-dimensional reference-free averages used for each three-dimensional
reconstruction are shown in the left panels and sections of each of themodels (right panels). The scale bar represents 25 Å.D, angular refinement of YY1 dimer
(complex A). Initial refinement was performedwithout imposing any symmetry (steps 1 and n) using the RCTmodel #01 shown in C as the initial template, and
after convergence, c2 rotational symmetry was imposed and further refined (Final volume). Volumes are shown rendered at a threshold representing around
75% of the protein mass for visualization of structural features. The scale bar represents 25 Å. E, three-dimensional structure of the YY1 dimer (complex A)
obtained after angular refinement. The scale bar represents 25 Å. Characteristic regions of the complex, defined as head and arm, are labeled. The left panel
shows the comparison of the computational projections (Proj.) of the refined volumewith the averages (Aver.) of the singlemolecule images assigned to each
orientation. The scale bar represents 5nm. F, angular refinement of YY1 complexAusing several initial volumes as templates todiscard a significantmodel bias.
Refinementwasperformedapplying 2-fold rotational symmetry andusing as templates: a randomconical tilt structure, a reconstructionobtainedby common
lines, or using the Startcsym command in EMAN (33) and a featureless blob usingmethods defined in EMAN2 (32). In all cases refinements converged to very
similar structures (Refined volume). The scale bar represents 25 Å.
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images in the electron microscope suggested the assembly of
an YY1 dimer.
Dimerization of YY1 was further supported by solving the
structure of these oligomers using 16,362 images obtained in
the electron microscope (Fig. 3E). First, a three-dimensional
reconstruction of YY1was obtained by image processingmeth-
ods and using an ab initio RCT structure as the initial template
(model #01 in Fig. 3C) for refinement and applying no symme-
try constrains (Fig. 3E). The estimated molecular mass of this
non-symmetrized reconstruction, defined by the number of
voxels occupied by the reconstruction and assuming an average
density for proteins, was 100 kDa, which only matched a
dimeric species. Then, 2-fold symmetry was applied to obtain
the structure of YY1 complexA at 20Å resolution (Fig. 3E). The
structure of the YY1 revealed two regions (Fig. 3E). The top
region (“head”) was compact and displayed a square shape and
was therefore responsible for the strong component of 4-fold
symmetry detected in the averages (Fig. 3B). The bottom region
(the “arms”) was slightly elongated and fitted better to 2-fold
symmetry. To rule out a significant bias of the initial template
during image processing, we confirmed that the data converged
to very similar reconstructions when using several initial mod-
els obtained by distinct methods: RCT, common lines, use of
rotational symmetry, and a featureless blob (see “Experimental
Procedures” for details) (Fig. 3F).
YY1 Multimerizes by the Association of Dimers—The struc-
tural characterization of YY1 complex B was first addressed by
concentrating His-YY1 to enrich the complex, but this resulted
in its aggregation. We then produced an N-terminal Strep-II-
tagged version (Strep-II-YY1) that yielded a major peak com-
posed of abundant complex B in SEC (Fig. 4A). Strep-II-YY1
behaved as a discrete high molecular weight band in SDS-
PAGE after stabilization with a mild concentration of glutar-
aldehyde using the GraFix method (29) (Fig. 4B), clearly
indicative of a defined oligomeric species. Images of Strep-
II-YY1 complex B revealed an elongated molecule (Fig. 4C),
and similar images were obtained for the complex after Gra-
Fix (not shown) and for His-YY1 complex B (Fig. 4D). A
minor percentage of Strep-II-YY1 complex A co-existed in
the same micrographs (20% of the data set) (Fig. 4C), and ab
initio RCT structures for each complex were obtained by the
RCT method to deal with this heterogeneity. Complex B
(80% of the data set) appeared as elongated structures of
roughly 100 Å in length, approximately double in size than
the dimers (Fig. 4E). We were unable to refine these struc-
tures to higher resolutions despite rigorous attempts. Major
difficulties were found to assign each molecule image to a
certain conformation as well as the ambiguities to define the
axis of rotational symmetry. Nonetheless, the two-dimen-
sional averages of the complexes and their RCT structures
suggested that these were distinct oligomeric species assem-
bled by the association of dimers, and several models could
be possible (Fig. 4F).
YY1 Oligomers Can Bind DNA with and without the Consen-
sus Sequence—Zinc finger motifs of YY1 define its function as a
transcription factor by recognizing a consensusDNAsequence.
We verified that Strep-II-YY1 oligomeric fractions obtained by
SEC (Fig. 5A) recognize a short dsDNA (20-bp) and 4-way HJ,
containing a consensus sequence (CCAT) by EMSA (Fig. 5, B
and C, Table 1). Unexpectedly, we found that YY1 oligomers
could also bind a 25-bp dsDNA without a consensus sequence
(although with less affinity than the dsDNAwith the consensus
sequence) and a HJ without a consensus sequence (Fig. 5, B–E),
suggesting these oligomers could have acquired new DNA
binding properties. The DNA mobility shifts observed corre-
lated with YY1 present in the fractions as revealed when the
native gels were analyzed by Western blot with an anti-YY1
antibody (Fig. 5, B–E, bottom panels). Maximum binding was
detected for the peak fraction enriched in YY1 oligomers,
mainly complex B. These results revealed that YY1 can bind
DNA after oligomerization, and remarkably these oligomers
seem to have the potential to recognize some DNA sub-
strates even when lacking the consensus sequence.
RuvBL1-RuvBL2 Interacts with YY1 and Enhances DNA
Binding—YY1has been shown to bindRuvBL1 andRuvBL2 (18,
19), and thus we decided to analyze if the oligomeric forms of
YY1 also interacted with these ATPases and how this could
affect DNA binding. RuvBL1 and RuvBL2 assemble homo-
hexameric rings on their own, whereas its co-expression results
in a mixture of hetero-hexameric and dodecameric complexes
that are believed to be functional forms of these ATPases in the
cell (23–25). We purified His-RuvBL1, His-RuvBL2, and His-
RuvBL1-RuvBL2 complexes and also RuvBL1-RuvBL2 where
the tag was removed (27) (Fig. 6A), and the oligomeric state of
each sample was characterized by SEC (Fig. 6B). Purified His-
RuvBL1 was resolved as a mixture of oligomers and free sub-
units, whereas His-RuvBL2 did not oligomerize under our
experimental conditions. On the other hand, His-RuvBL1-
RuvBL2 and RuvBL1-RuvBL2 formed hetero-oligomeric com-
plexes with an approximate 1:1 ratio that we interpreted as
hexamers and dodecamers based on previous information (27).
We found that Strep-II-YY1 interacted with His-RuvBL1 but
not His-RuvBL2 under our experimental conditions after pull-
ing down the Strep-II tag and eluting the retained His-RuvBL1
or His-RuvBL2 with D-desthiobiotin (Fig. 6C, lanes 3 and 5).
Similar experiments performed using purified His-RuvBL1
hexamers ormonomers retrieved identical results (not shown),
indicating that Strep-II-YY1 interacts with these two forms of
His-RuvBL1. Also, we observed that RuvBL1-RuvBL2 (either
containing or not the His tag) was also eluted in complex with
Strep-II-YY1 (Fig. 6D; note that His-RuvBL1 and RuvBL1 run
differently on SDS-PAGE).
We analyzed how the interaction between YY1 and RuvBL1-
RuvBL2 affected DNA binding by EMSA, and we focused on
two dsDNAs, one containing and another onemissing the con-
sensus sequence for YY1 (Fig. 7), and compared its binding
affinity to the binding to a HJ DNA without a consensus
sequence. We first measured the affinity of each protein for
these forms of DNA and included also ssDNA in our analysis
(Fig. 7A, Table 2). The interaction of YY1 with both dsDNAs
mainly revealed two types of complexes, a single band of shifted
DNA and a complex migrating at the gel well at high protein
concentrations (Fig. 7A, left panel). YY1 bound 4–5 times bet-
ter to the dsDNA containing the consensus sequence, but the
difference in binding affinity between the specific DNA and HJ
DNA was only 2–3 times (Table 2). Binding to ssDNA was also
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observed. The analysis of the binding of RuvBL1-RuvBL2 to
DNA showed that the preferred substrate was HJ (J3) followed
by the 80-nt ssDNA (Fig. 7A, right panel; Table 2). RuvBL1-
RuvBL2 bound DNA forming several complexes. Interestingly,
when RuvBL1-RuvBL2 and YY1were incubated together in the
presence of a dsDNA with or without the consensus sequence,
we observed that the top bands corresponding to DNA shifted
by YY1were enhanced significantly (Fig. 7B, compare lane 6 for
FIGURE 4. YY1 multimerizes in larger complexes by the association of YY1 dimers. A, purification of Strep-II-YY1. Left panel, SDS-PAGE and SimplyBlue
(Invitrogen) staining of purified Strep-II-YY1. Right panel, SEC of Strep-II-YY1 using a Superdex 200 PC 3.2/30 (GE Healthcare) column. Molecular weight
standards (GE Healthcare) used for column calibration are indicated on the top of the chromatogram. B, silver staining SDS-PAGE of the Strep-II-YY1 protein
purified and stabilized by the GraFix method in a glycerol/glutaraldehyde (GA) gradient (right panel) and in a glycerol gradient (left panel). C, selected raw
molecule images and reference-free averages of Strep-II-YY1 (complexes A and B). The scale bar represents 10 nm. 2D averages, two dimensional averages. D,
rawmolecule images and reference-free averagesofHis-YY1 (complexesA andB). Images for both samples (His- andStrep-II-taggedYY1)were similar. The scale
bar represents 10 nm. E, representative RCT structures obtained from images and averages of Strep-II-YY1. The peak from the SEC contained a mixture of
complexes A and B. The scale bar represents 25 Å. The two-dimensional averages of the images used for each RCT reconstructions are shown in the left panels.
The scale bar represents 5 nm. F, hypothetical models for the association of YY1. Two potential ways of association of YY1 dimers into larger oligomers, based
on the two-dimensional averages and the RCT structures of complexes A and B, are proposed.
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YY1 alone with lanes 7–9 for YY1 incubated with RuvBL1-
RuvBL2). Experiments were done at a YY1 concentration that
resulted in 10% of DNA shifted in the absence of RuvBL1-
RuvBL2, and at the highest RuvBL1-RuvBL2 concentration
used (700 nM), a 5-fold increase in the amount of YY1 com-
plexes with the consensus sequence and a 7-fold for YY1 com-
plexes with dsDNA without the consensus sequence was
observed. Similar effects were found for ssDNA (Fig. 7C) and a
HJ (Fig. 7D). Control experiments were performed where the
different DNA substrates were incubated with YY1 and an
excess of BSA to demonstrate that the enhancement in binding
is not due to a “protein concentration” stabilizing effect (data
not shown).
Taken together, these results are a strong indication that YY1
and RuvBL1-RuvBL2 can form a complex with increased affinity
for DNA. Interestingly, these effects are found to occur also when
the DNA does not contain the consensus sequence for YY1.
YY1 and RuvBL1-RuvBL2 Cooperate in Vivo to Promote
RAD51 Foci Formation during Homologous Recombination—
YY1 functions in HR as part of the INO80 complex (containing
RuvBL1 and RuvBL2 subunits), and although the mechanism
for this is unknown, it has been suggested that it could occur
FIGURE 5.YY1 oligomers recognize DNAwith andwithout the consensus sequence. A, purified Strep-II-YY1was fractionated as in Fig. 4A and analyzed by
SDS-PAGE and silver-staining. Molecular weight markers used for SEC calibration are indicated above the gel. B, EMSA using the fractions from the SEC
experiment shown inA andadsDNAcontaining the consensus sequence for YY1 (CCAT) (describedasdsDNA_sp_2under “Experimental Procedures”).C, EMSA
as in Bbut using a dsDNA that does not contain the consensus sequence (described as dsDNA_no_sp_2 under “Experimental Procedures”).D, EMSA as in Bbut
using a synthetic 4-way HJ containing the consensus sequence for YY1 (CCAT) (described as HJ_25_sp under “Experimental Procedures”). E, EMSA as in D but
using a synthetic 4-way HJ that does not contain the consensus sequence (described as HJ_25_no_sp under “Experimental Procedures”). Lanes labeled as C
(B–E) show the nucleic acid in each case in the absence of protein. The bottom panels (B–E) show the same gels, run for longer, and where the presence of YY1
in the shifted DNA was detected by Western blot with an anti-YY1 antibody (-YY1).
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through the recognition of Holliday junction-like structures
(15). Our findings showing that the interaction of YY1 and
RuvBL1-RuvBL2 enhances binding to ssDNA and dsDNA
prompted us to further define their role during HR. We
explored if these proteins cooperate at several stages of the HR
process where HJ substrates are not available and also the
requirement of catalytic activity of the RuvBL1-RuvBL2
ATPases. To investigate this, we transfected cells with siRNA
targetingYY1 and examined themafter treatmentwith ionizing
radiation (IR) (Fig. 8). HR is restricted to the S and G2 phases of
the cell cycle in mammalian cells, so we immunostained for
CENPF to identify G2 phase cells and then measured the accu-
mulation ofDNAdamage response factors into IR induced foci.
We found that the number of phosphorylatedH2AX (H2AX)-
containing foci at the 2-h time point was unaffected by deple-
tion of YY1 (Fig. 8A), suggesting that the initial detection and
signaling of the DNA breaks are unaltered. At 8 h after treat-
ment, the BRCA2 (breast cancer type 2 susceptibility protein)-
depleted cells, which are HR-defective, showed a modest
increase in foci at this time point (Fig. 8A).
After recognition, DNA breaks are resected to leave 3
ssDNA overhangs that are bound by RPA. Subsequent to resec-
tion, BRCA2 mediates the replacement of RPA with RAD51
filaments on the ssDNA overhang, and the RAD51 filament
performs the homology search and strand invasion steps (40).
When we examined RPA foci formation in G2 cells, we found
no difference in the number of foci in the cells depleted for YY1
when compared with control cells (Fig. 8B). Whereas it is pos-
sible that the extent of resection is affected, this result suggests
that there is no defect in the number of resected DNA breaks in
these cells. Cells depleted for BRCA2 show normal H2AX and
RPA foci but defective RAD51 foci after IR (Fig. 8, B and C).
Similar to loss of BRCA2, we found that there were significantly
fewer RAD51 foci in the YY1 and RuvBL2 depleted cells,
although the severity of the defect was not as pronounced as in
the BRCA2-depleted cells (Fig. 8C). Notably, we found that
depletion of RuvBL2 recapitulated HR defects after YY1 deple-
tion. Specifically, the numbers of H2AX and RPA foci were
largely unaffected by depletion of RuvBL2, but the number of
RAD51 foci was reduced to similar levels as those observed in
YY1-depleted cells (Fig. 8).
These results showed that depletion of YY1 or RuvBL2
resulted in comparable HR defects, suggesting that YY1 and
RuvBL2 could cooperate to promote or stabilize RAD51 fila-
ment formation. To investigate whether this was the case, we
analyzed the formation of H2AX, RPA, and RAD51 foci in G2
cells following IR exposure after depletion of YY1, RuvBL2, or
both (Fig. 9A). If these subunits were functioning at separate
steps during HR, we would predict an increase in unrepaired
breaks when they are co-depleted, leading to an increase in
H2AX foci. Furthermore, if YY1 and RuvBL2 were promoting
or stabilizing RAD51 foci formation via distinct mechanisms,
depletion of both proteins would result in a greater defect in
RAD51 foci relative to cells with depletion of a single subunit.
However, we found that both H2AX and RAD51 foci forma-
tions were similar in cells depleted of both proteins to cells
depleted of either individual subunits (Fig. 9B), indicating that
these genes function on the same pathway to promote HR.
Wemade use of a point mutation within theWalker Amotif
of RuvBL2 that impairs ATP binding but does not disrupt its
folding (41) to determine whether the ATPase activity of
RuvBL2 is required for the observed effect on RAD51 foci
formation after IR exposure. To do this we generated a
siRNA-resistant GFP-tagged RuvBL2 expression construct
and then introduced the K83A point mutation into this con-
struct (Fig. 9C). We then transfected the wild type and
mutant constructs (along with a GFP control) alongside
siRNA directed against RuvBL2 and analyzed H2AX and
RAD51 foci formation in GFP-positive G2 cells. We found
that the wild type construct was able to complement the
RAD51 foci formation defect of the RuvBL2-depleted cells,
whereas the mutant construct was not able to complement
the defect (Fig. 9D), indicating that the ATPase activity of
RuvBL2 is required during this step of HR. All these data
suggest that the epistatic function of YY1 and RuvBL1-
RuvBL2 during HR requires the catalytic activity of these
ATPases, at least in the case of RuvBL2.
TABLE 1
Sequences of oligonucleotides used for constructing several DNA substrates
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Recombinant YY1 was previously shown to behave as an oli-
gomer in SEC and glutaraldehyde cross-linking experiments
(15). Our structural characterization of the transcription factor
YY1 not only confirms those results using His-YY1 and Strep-
II-YY1, but in addition it offers a deeper understanding of the
architecture of these oligomers.We determine that YY1 assem-
bles as dimers that can associate into larger oligomeric com-
plexes, and we characterize the structural organization of these
oligomers using EM. Moreover, we show that the self-associa-
tion of YY1 also occurs in vivo. The most characteristic struc-
tural feature for the transcription factor YY1 is the C-terminal
C2H2-type zinc finger motifs (11). Although the main function
of these motifs is to interact with nucleic acids, they have been
also implicated in protein-protein interactions, including in
some cases homo-dimerization (42–44). One example is
Ikaros, a protein containing six C2H2-type zinc fingers, four of
which are involved in DNA binding and the two C-terminal
fingers are responsible for the assembly of a homodimer (45).
Thus, it is conceivable that YY1 could use, at least in part, these
multifunctional zinc fingers to homo-dimerize. Interestingly,
dimerization of Ikaros dramatically increased its affinity for
DNA, and a similar effect could be taking place in the case of
YY1 (see below).
YY1 zinc finger motifs are responsible for specifically bind-
ing to a consensus DNA sequence (5-(C/g/a)(G/t)(C/t/a)-
FIGURE 6. Analysis of the interaction of purified YY1 with RuvBL1 and RuvBL2. A, SDS-PAGE and SimplyBlue (Invitrogen) staining of purified His-RuvBL1,
His-RuvBL2, His-RuvBL1-RuvBL2, and RuvBL1-RuvBL2. B, chromatograms and SDS-PAGE analysis of the fractions from a SEC of His-RuvBL1, His-RuvBL2, and
His-RuvBL1-RuvBL2 (solid line) and RuvBL1-RuvBL2 (dash line) using a Superdex 200 PC 3.2/30 (GEHealthcare) column. Proteinswere stained using SimplyBlue
(Invitrogen) (His-RuvBL1,His-RuvBL1-RuvBL2, andRuvBL1-RuvBL2) or by silver staining (His-RuvBL2). Thepositions for thedifferent oligomeric species (12-mer,
dodecamer; 6-mer, hexamer; 1-mer, monomer) are indicated in each case and were determined by comparison with molecular weight standards. The asterisk
(*) in the case of His-RuvBL1 SEC indicates a peak of aggregated material as observed by EM. C, pulldown experiments of Strep-II-YY1 and His-RuvBL1 or
His-RuvBL2. Strep-II-YY1was incubatedwithout (lane 1) or with His-RuvBL1 (lane 3) or His-RuvBL2 (lane 5) and affinity purified using the Strep-II-tag present in
YY1. As a control, His-RuvBL1 (lane 2) or His-RuvBL2 (lane 4) was purified in the same conditions but in the absence of YY1. D, pulldown experiments of
Strep-II-YY1andHis-RuvBL1-RuvBL2orRuvBL1-RuvBL2. Strep-II-YY1was incubatedwithout (lane1) orwithHis-RuvBL1-RuvBL2 (lane3) or RuvBL1-RuvBL2 (lane
5) and affinity-purified as in A. As a control, His-RuvBL1-RuvBL2 (lane 2) or RuvBL1-RuvBL2 (lane 4) was pull downed in the same conditions as those before but
in the absence of YY1.
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FIGURE 7. YY1 and RuvBL1-RuvBL2 cooperate in DNA binding. A, left panel, EMSA assays showing binding of Strep-II-YY1 to several DNA substrates
(described under “Experimental Procedures”) and represented as a schematic in each gel. Binding reactions contained 0, 240, 120, 60, or 30 nM protein
and 0.3 nM DNA species: HJ (J3) (lanes 1–5), dsDNA non-consensus sequence (dsDNA_no_sp_1) (lanes 6–10), 80-nt ssDNA (lanes 11–14), and dsDNA
consensus sequence (dsDNA_sp_1) (lanes 15–19). Right panel, EMSA assays showing binding of His-RuvBL1-RuvBL2 to the sameDNA substrates. Binding
reactions contained 0, 1.4, 0.7, 0.35, or 0.17 M protein and 0.3 nM DNA species: HJ (J3) (lanes 1–5), dsDNA non-consensus sequence (dsDNA_no_sp_1)
(lanes 6–10), 80-nt ssDNA (lanes 11–14), and dsDNA consensus sequence dsDNA_sp_1) (lanes 15–19). Reactions were performed as described under
“Experimental Procedures,” and protein-DNA complexes were visualized by 6% PAGE and autoradiography. B, RuvBL1-RuvBL2 enhances the binding of
YY1 to dsDNA either containing (right panel, dsDNA_sp_1) or not the consensus sequence (left panel, dsDNA_no_sp_1). Reactions assembled on ice
contained combinations of a decreasing concentration of His-RuvBL1-RuvBL2 (1.4, 0.7, 0.35 or 0.17M) and a fixed concentration of Strep-II-YY1 (120 nM
in the left panel and 15 nM in the right panel). After DNA addition (0.3 nM), samples were incubated for 30 min at 37 °C before electrophoresis. C, YY1 and
RuvBL1-RuvBL2 also cooperate in ssDNA binding. Shown is a similar experiment as B but using a 80-nt ssDNA (0.3 nM) (lanes 1–9). His-RuvBL1-RuvBL2
concentrations were varied as indicated from 700 to 87 nM, and the fixed concentration of Strep-II-YY1 used was 120 nM. D, EMSA of the enhancement
in binding of Strep-II-YY1 to HJ (J3) (0.3 nM) in the presence of the indicated concentrations His-RuvBL1-RuvBL2 (concentrations are expressed in nM).
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CATN(T/a)(T/g/c)-3) found at the promoters of target genes
(11). DNA binding by the oligomeric forms of YY1 is not well
characterized, and the work byWu et al. (15) used nucleic acid
substrateswith a consensus sequence for YY1,where it could be
difficult to identify interactions with DNA distinct to those as a
transcription factor. In this context, one significant new finding
of our study is that these oligomers can interact with several
DNAs that do not contain the consensus sequence, at least in
vitro. This is consistent with the finding that YY1 binds to RNA
during inactivation of one X chromosome in mammalian
females independent of a consensus motif (4). What could be
the molecular/structural basis for these unconventional inter-
actions between YY1 and nucleic acids? C2H2-type zinc finger
domains can bind, in addition to DNA, to several nucleic acids
such as ssRNA, dsRNA, and DNA-RNA hetero-duplexes (44),
although the structural basis for these properties are poorly
FIGURE8.YY1andRuvBL2functionduringG2topromoteRAD51foci formation,butnotH2AXorRPAfoci,afterexposuretoIR.A,A549cellsweretransfected
with scrambledsiRNA (siCTR) or siRNAdirectedagainstYY1,RuvBL2,orBRCA2, irradiated (3Gy)andharvested2or8h later and immunostained forH2AXandCENPF
(to identify G2 phase cells). Average H2AX foci per G2 cell were quantified (right panel). B, cells transfected as in A were irradiated (3 Gy), harvested after 2 h, and
immunostained for RPAandCENPF. AverageRPA foci perG2 cellwerequantified (right panel).C, cells transfected as inAwere immunostained for RAD51andCENPF,
and average RAD51 foci per G2 cell were quantified (right panel). All data (A–C) are themeans of3 experiments; error bars, S.D.
TABLE 2
DNA binding affinities of YY1 and RuvBL1-RuvBL2




80-nt ssDNA 180 1.8
Holliday junction J3 90 1
a The apparent binding constant (Kd app) for each substrate was determined from
a compilation of at least three separate gel shift experiments, each with a dilu-
tion series of protein and a DNA substrate concentration fixed at 0.3 nM.
b The Kd app for this substrate is estimated, because at the maximal protein con-
centration tested (2 M)25% of the DNA was retained.
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understood. One hypothesis might be that the oligomerization
of YY1 could expand its properties to bind DNA, RNA, and/or
other proteins by the combination of zinc fingers motifs from
several monomers. This opens the possibility that, when in the
form of larger oligomers and/or as part of larger complexes,
YY1 could contribute to functions unrelated to those of a tran-
scription factor. Interestingly, recent reports describe roles of
YY1 in distinct functions such as proviral silencing in embry-
onic cells (6), the regulation of the expression of long non-
coding RNAs during myogenesis (7), and in V(D)J somatic
rearrangement of Ig loci during B-cell development by a mech-
anism that involves long distance DNA interactions (46).
One of these unconventional functions is the link between YY1
and DNA repair (15, 47). We predict that the functions of YY1 in
DNA repair should be independent of the recognition of specific
sequences, andour results indicate thatYY1has thepotential todo
so. We corroborate that YY1 functions in HR, but in addition,
our data suggest that defects in HR observed in the absence of
YY1 may be due to, at least in part, an inability to efficiently
promote formation or stabilization of the RAD51 filament.
FIGURE 9. RuvBL2 cooperateswith YY1 to promote RAD51 foci formation, and the ATPase activity of RuvBL2 is required for this activity. A, A549 cells were
transfectedwithscrambledsiRNA(siCTR) or siRNAsdirectedagainstYY1,RuvBL2,orBRCA2,as indicated, irradiated (3Gy),harvested2or8h later, and immunostained
forH2AXandCENPF (to identify G2 phase cells). AverageH2AX foci perG2 cell were quantified (right panel). B, cells treated as inAwere immunostained for RAD51
and CENPF, and average RAD51 foci per G2 cell were quantified (right panel). All data (A and B) are themean of3 experiments; error bars, S.D. C, top, Western blot
analysis ofwhole cell extracts prepared fromA549cells transfectedwith the indicated siRNA.Bottom,Westernblot analysis ofwhole cell extracts prepared fromA549
cells transfectedwith single or double siRNA constructs as indicated. Anti-KAP1 is shown as a loading control.D, U2OS cells transfectedwith siRNA directed against
RuvBL2 andeitherGFP, GFP-RuvBL2, or GFP-RuvBL2-K83Awere irradiated (3Gy), harvested, and immunostained for RAD51 andCENPF. Average RAD51 foci perGFP
positive G2 cell were quantified and are presented as themeans of three experiments; error bars, S.D.
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A direct interaction of YY1 with RuvBL1 and RuvBL2 has
been previously described (15). These AAA ATPases are
implicated in several cellular processes as part of large macro-
molecular assemblies, such as INO80, SWR1, TIP60, and R2TP
complexes, among others (20, 21). Despite both proteins being
essential, not much is known about their mechanism of action,
and the functional significance of the several oligomeric forms
of RuvBL1 and RuvBL2 is still unclear (20, 21). We tested the
interaction of YY1 with the RuvBL1 and RuvBL2 ATPases,
showing that this interaction takes place also with purified YY1
oligomers. In addition, we observed that YY1 binds RuvBL1-
RuvBL2 complexes, but YY1 interacts preferentially with
RuvBL1, and it associates to RuvBL2 mostly when this is in
complex with RuvBL1. We cannot rule out that RuvBL2 could
bind YY1 at higher concentrations.
Unexpectedly, we found that when YY1 and RuvBL1-
RuvBL2 are incubated together with several DNA substrates,
they interact with the nucleic acids with enhanced affinity com-
pared with each protein on their own, and this effect is espe-
cially relevantwhen considering thoseDNAswithout a consen-
sus sequence. YY1 forms a complex with DNA that is detected
as a lowermigrating band in EMSA experiments, and the abun-
dance of this complex is enhanced 7-fold in the presence of
RuvBL1-RuvBL2. These results suggest that YY1 and RuvBL1-
RuvBL2 cooperate to enhance binding toDNA. Similar findings
have been recently described for another transcription factor,
GATA-binding protein 3 (Gata3), which controls differentia-
tion of T cells (48). Gata3 forms a complex with RuvBL2, and it
was proposed that the interaction promoted the DNA binding
activity of Gata3.
Thus, the interaction of YY1with RuvBL1 andRuvBL2 either
alone or as part of a larger complex could represent a mecha-
nism to modify the functionality of this transcription factor.
The molecular/structural bases for this remain to be explored,
but RuvBL1-RuvBL2 contains two regions with the potential to
bind nucleic acids. Domain II shows a structure reminiscent of
RPA, and recombinant DII domains from RuvBL1 in isolation
bind ssRNA, ssDNA and dsDNA (24). Similar to other AAA
family members, RuvBL1 and RuvBL2 assemble hexameric
complexes with a central channel that could potentially bind
ssDNA (24), although this has not been demonstrated experi-
mentally. YY1 could cooperate with any of these two potential
DNA binding sites in RuvBL1-RuvBL2 to enhance the affinity
for nucleic acids, somehowmimicking the behavior of the bac-
terial homolog RuvB, which has poor DNA binding itself and
needs to interact with RuvA to bind DNA structures (22). The
mechanism of how exactly YY1, RuvBL1, and RuvBL2 proteins
cooperate to promote steps during HR and/or other cellular
events needs to be further explored. Here we provide evidence
suggesting an important role of the RuvBL1-RuvBL2 ATPases
in enhancing the DNA binding properties of YY1, which could
be directly linked to the regulation of different cellular pro-
cesses, including transcription and DNA repair.
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